10-02-2022, 10:15 AM
Findings of this cross-sectional analysis of unvaccinated US adults indicated that anti-SARS-CoV-2 RBD antibodies were detected in 99%, 55%, and 11% of confirmed COVID-19, unconfirmed COVID-19, and no-COVID groups of the study population, respectively.
In contrast to the previous six-month longevity data, the anti-RBD antibodies were present in the COVID-19-positive patients for up to 20 months.
https://www.news-medical.net/news/202202...onths.aspx
In contrast to the previous six-month longevity data, the anti-RBD antibodies were present in the COVID-19-positive patients for up to 20 months.
https://www.news-medical.net/news/202202...onths.aspx